Serum for Covishield

Serum Institute of India applies for emergency approval of covid vaccine candidate ‘Covishield’

FILE PICSerum Institute of India (SII) has applied for emergency approval of made-in-India covid vaccine candidate, Covishield.

SII CEO Adar Poonawalla has confirmed it and said it will save countless lives.

He also thanked the Government of India and Prime Minister Narendra Modi for their invaluable support.

SII, the world’s largest vaccine producer by volume, had sought emergency use authorization in the country for AstraZeneca Plc’s COVID-19 vaccine candidate.

The company applied to the Drugs Controller General of India, citing unmet medical needs due to the pandemic and in the interest of the public at large. 

The move comes close on the heels of Pfizer Inc applying for a similar authorization of its coronavirus vaccine in India.

By Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

One reply on “Serum for Covishield”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s